NS

Nalimeli Sai Priya

Active Director Director DIN 11652153
DIN 11652153 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nalimeli Sai Priya

Data last updated:

Nalimeli Sai Priya is a Director at Sri Tulasi Ayurvedic Hospitals Private Limited (since 2026) and Director at Sri Tulasi Foundation (since 2026).

DIN 11652153
Primary Designation Director
First Appointment 07 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Sep 20262026Active
Sri Tulasi Foundation U86901AP2026NPL125185
Director07 Apr 20262026Active

Directorship timeline

Open interactive timeline →
Sri Tulasi Foundation
Sri Tulasi Ayurvedic Hospitals Private Limited
Premium access

Shareholding and investment profile for Nalimeli Sai Priya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nalimeli Sai Priya

Nalimeli Sai Priya currently holds 2 directorships: Sri Tulasi Ayurvedic Hospitals Private Limited (Director, since 10 Sep 2026); Sri Tulasi Foundation (Director, since 07 Apr 2026).

Nalimeli Sai Priya was first appointed on 07 Apr 2026 as Director at Sri Tulasi Foundation.

The current boards of Nalimeli Sai Priya's companies include Nalimali Sobharani (Sri Tulasi Ayurvedic Hospitals Private Limited), Neranetham Kodandaachari (Sri Tulasi Ayurvedic Hospitals Private Limited), Neranetham Sivaprasad (Sri Tulasi Ayurvedic Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available